Elizabeth Murphy Lilly
First SEC filing: Dec. 17, 2020 · Latest: April 2, 2025
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Sept. 30, 2026 | APOG | A | 0 | $35.37 | · | 9,755 Direct | 0.00% | Acquired | 13.1% (price as of 2026-10-06) |
| June 30, 2026 | APOG | A | 41 | $45.74 | $1,875 | 9,682 Direct | +0.43% | Acquired | -12.5% (price as of 2026-10-06) |
| June 24, 2026 | APOG | A | 2,741 | $41.96 | $115,012 | 9,641 Direct | +39.72% | Acquired | -4.7% (price as of 2026-10-06) |
| March 31, 2026 | APOG | A | 55 | $33.54 | $1,845 | 6,900 Direct | +0.80% | Acquired | 19.3% (price as of 2026-10-06) |
| Dec. 31, 2025 | APOG | A | 0 | $36.41 | · | 6,845 Direct | 0.00% | Acquired | 9.9% (price as of 2026-10-06) |
| Sept. 30, 2025 | APOG | A | 39 | $43.57 | $1,699 | 6,796 Direct | +0.58% | Acquired | -8.2% (price as of 2026-10-06) |
| June 30, 2025 | APOG | A | 24 | $40.60 | $974 | 6,757 Direct | +0.36% | Acquired | -1.5% (price as of 2026-10-06) |
| June 25, 2025 | APOG | A | 2,954 | · | · | 6,733 Direct | +78.17% | Acquired | (price as of 2026-10-06) |
| March 31, 2025 | APOG | A | 21 | $46.33 | $973 | 3,779 Direct | +0.56% | Acquired | -13.7% (price as of 2026-10-06) |
| Dec. 31, 2024 | APOG | A | 0 | $71.41 | · | 3,758 Direct | 0.00% | Acquired | -44.0% (price as of 2026-10-06) |
| Sept. 30, 2024 | APOG | A | 0 | $70.02 | · | 3,744 Direct | 0.00% | Acquired | -42.9% (price as of 2026-10-06) |
| June 28, 2024 | APOG | A | 0 | $62.84 | · | 3,732 Direct | 0.00% | Acquired | -36.3% (price as of 2026-10-06) |
| June 20, 2024 | APOG | A | 1,893 | · | · | 3,725 Direct | +103.33% | Acquired | (price as of 2026-10-06) |
| March 28, 2024 | APOG | A | 8 | $59.20 | $474 | 1,832 Direct | +0.44% | Acquired | -32.4% (price as of 2026-10-06) |
| Dec. 29, 2023 | APOG | A | 8 | $53.41 | $427 | 1,824 Direct | +0.44% | Acquired | -25.1% (price as of 2026-10-06) |
| Sept. 29, 2023 | APOG | A | 9 | $47.08 | $424 | 1,816 Direct | +0.50% | Acquired | -15.0% (price as of 2026-10-06) |
| June 21, 2023 | APOG | A | 1,807 | · | · | 1,807 Direct | · | Acquired | (price as of 2026-10-06) |
| June 21, 2023 | APOG | A | 602 | · | · | 12,488 Direct | +5.06% | Acquired | (price as of 2026-10-06) |
| June 22, 2022 | APOG | A | 2,773 | · | · | 11,886 Direct | +30.43% | Acquired | (price as of 2026-10-06) |
| June 24, 2021 | APOG | A | 2,721 | · | · | 9,113 Direct | +42.57% | Acquired | (price as of 2026-10-06) |
| June 24, 2020 | APOG | A | 4,920 | · | · | 6,392 Direct | +334.24% | Acquired | (price as of 2026-10-06) |
| Jan. 14, 2020 | APOG | A | 1,472 | · | · | 1,472 Direct | · | Acquired | (price as of 2026-10-06) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Sept. 30, 2026 | APOG | Deferred Restricted Stock Units [F1] | Common Stock | · | · | 0 | Acquired |
| June 30, 2026 | APOG | Deferred Restricted Stock Units [F1] | Common Stock | · | · | 41 | Acquired |
| June 24, 2026 | APOG | Deferred Restricted Stock Units [F1] | Common Stock | · | · | 2,741 | Acquired |
| March 31, 2026 | APOG | Deferred Restricted Stock Units | Common Stock | · | · | 55 | Acquired |
| Dec. 31, 2025 | APOG | Deferred Restricted Stock Units [F1] | Common Stock | · | · | 0 | Acquired |
| Sept. 30, 2025 | APOG | Deferred Restricted Stock Units [F1] | Common Stock | · | · | 39 | Acquired |
| June 30, 2025 | APOG | Deferred Restricted Stock Units [F1] | Common Stock | · | · | 24 | Acquired |
| June 25, 2025 | APOG | Deferred Restricted Stock Units [F1] | Common Stock | · | · | 2,954 | Acquired |
| March 31, 2025 | APOG | Deferred Restricted Stock Units | Common Stock | · | · | 21 | Acquired |
| Dec. 31, 2024 | APOG | Deferred Restricted Stock Units [F1] | Common Stock | · | · | 0 | Acquired |
| Sept. 30, 2024 | APOG | Deferred Restricted Stock Units [F1] | Common Stock | · | · | 0 | Acquired |
| June 28, 2024 | APOG | Deferred Restricted Stock Units [F1] | Common Stock | · | · | 0 | Acquired |
| June 20, 2024 | APOG | Deferred Restricted Stock Units [F1] | Common Stock | · | · | 1,893 | Acquired |
| March 28, 2024 | APOG | Deferred Restricted Stock Units [F1] | Common Stock | · | · | 8 | Acquired |
| Dec. 29, 2023 | APOG | Deferred Restricted Stock Units [F1] | Common Stock | · | · | 8 | Acquired |
| Sept. 29, 2023 | APOG | Deferred Restricted Stock Units | Common Stock | · | · | 9 | Acquired |
| June 21, 2023 | APOG | Deferred Restricted Stock Units | Common Stock | · | · | 1,807 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.